Baclofen Tablets USP — Class II drug recall D-0235-2026
Ongoing recall by Golden State Medical Supply Inc., reported 2025-12-24, distributed nationwide. Presence of Foreign Tablets/Capsules
| Recall number | D-0235-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Golden State Medical Supply Inc., Camarillo, CA, United States |
| Recall initiated | 2025-11-26 |
| Classified | 2025-12-15 |
| Reported by FDA | 2025-12-24 |
| Distributed | Nationwide (US) |
| Quantity | 2,472 hdpe |
| NDC | 51407-0972, 51407-0972-01, 51407-0973, 51407-0973-01, 51407-0973-10, 51407-0974, 51407-0974-01, 51407-0974-10 |
| Lot numbers | GS065762 |
Product
Baclofen Tablets USP, 10 mg, 1000-count bottles, Rx only, Marketed by: GSMS, Incorporated, CA 93012 USA. NDC 51407-973-10
Reason for recall
Presence of Foreign Tablets/Capsules
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0235-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.